|
Market Closed -
OTC Markets
12:40:55 2026-08-18 EDT
|
5-day change | 1st Jan Change | ||
| 7.000 USD | -3.98% |
|
0.00% | -6.67% |
| 08-28 | Frankfurt stocks close: Fed chief Warsh lifts Dax to another record high | DP |
| 08-28 | Redcare Pharmacy NV : Receives a Buy rating from Jefferies | ZD |
Company Valuation: Redcare Pharmacy NV
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 2,050 | 798.2 | 2,395 | 2,679 | 1,324 | 1,307 | - | - |
| Change | - | -61.07% | 200.06% | 11.86% | -50.57% | -1.33% | - | - |
| Enterprise Value (EV) 1 | 2,039 | 986.6 | 2,556 | 2,830 | 1,648 | 1,540 | 1,529 | 1,492 |
| Change | - | -51.62% | 159.04% | 10.72% | -41.74% | -6.57% | -0.76% | -2.39% |
| P/E | -27.3x | -10.2x | -180x | -58x | -34.8x | -131x | 57x | 23.5x |
| PBR | 4.94x | 2.26x | 5.09x | 5.54x | 2.85x | 2.72x | 2.59x | 2.32x |
| PEG | - | -2.49x | 2.2x | -0x | 2x | 1.8x | -0x | 0x |
| Capitalization / Revenue | 1.93x | 0.66x | 1.33x | 1.13x | 0.45x | 0.38x | 0.34x | 0.31x |
| EV / Revenue | 1.92x | 0.82x | 1.42x | 1.19x | 0.56x | 0.45x | 0.4x | 0.35x |
| EV / EBITDA | -408x | -123x | 47.8x | 85x | 28.7x | 16.1x | 11.8x | 9.07x |
| EV / EBIT | -63.1x | -20.7x | -674x | -81x | -135x | 69.6x | 31.7x | 18.7x |
| EV / FCF | -64.7x | -11.9x | 110x | -141x | -18.8x | -44.8x | 130x | 33.6x |
| FCF Yield | -1.55% | -8.38% | 0.91% | -0.71% | -5.31% | -2.23% | 0.77% | 2.97% |
| Dividend per Share 2 | - | - | - | - | - | 0.01 | - | - |
| Rate of return | - | - | - | - | - | 0.02% | - | - |
| EPS 2 | -4.15 | -4.32 | -0.73 | -2.27 | -1.87 | -0.4845 | 1.114 | 2.701 |
| Distribution rate | - | - | - | - | - | -2.06% | - | - |
| Net sales 1 | 1,060 | 1,204 | 1,799 | 2,371 | 2,941 | 3,427 | 3,833 | 4,230 |
| EBITDA 1 | -5 | -8.044 | 53.5 | 33.3 | 57.4 | 95.66 | 129.4 | 164.5 |
| EBIT 1 | -32.3 | -47.55 | -3.793 | -34.91 | -12.2 | 22.14 | 48.18 | 79.7 |
| Net income 1 | -74.2 | -77.65 | -12.04 | -45.46 | -37.7 | -10.05 | 23.09 | 58.08 |
| Net Debt 1 | -10.98 | 188.4 | 160.7 | 150.5 | 324.2 | 233.5 | 221.9 | 185.4 |
| Reference price 2 | 113.30 | 44.11 | 131.60 | 131.70 | 65.10 | 63.50 | 63.50 | 63.50 |
| Nbr of stocks (in thousands) | 18,095 | 18,095 | 18,199 | 20,342 | 20,342 | 20,578 | - | - |
| Announcement Date | 3/2/22 | 3/7/23 | 3/5/24 | 3/11/25 | 3/3/26 | - | - | - |
1EUR in Million2EUR
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 16.78x | 0.68x | 10.1x | -.--% | 14.92B | |
| 20.98x | 0.8x | 13.48x | 1.07% | 6.48B | |
| 16.99x | 0.77x | 7.98x | 2.19% | 6.45B | |
| 14.75x | 0.95x | 7.07x | 3.26% | 4.12B | |
| 14.61x | 1.25x | 7.66x | 5.51% | 3.25B | |
| 13.86x | 0.58x | 4.77x | 5.23% | 3.07B | |
| 13.83x | 0.83x | 6.24x | 4.64% | 2.91B | |
| 30.19x | - | - | - | 2.35B | |
| Average | 17.75x | 0.84x | 8.19x | 3.13% | 5.45B | |
| Weighted average by Cap. | 17.40x | 0.79x | 9.13x | 1.99% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- RDC Stock
- SAEYY Stock
- Valuation Redcare Pharmacy NV
Select your edition
All financial news and data tailored to specific country editions
